Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Manufacturing Operations: SOP for Sterile Handling of Ampoules during Manufacturing – V 2.0

Posted on By

Manufacturing Operations: SOP for Sterile Handling of Ampoules during Manufacturing – V 2.0

Standard Operating Procedure for Sterile Handling of Ampoules during Manufacturing


Department Manufacturing Operations
SOP No. SOP/MO/124/2025
Supersedes SOP/MO/124/2022
Page No. Page 1 of 15
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

This SOP outlines the procedures for sterile handling of ampoules during the manufacturing of injectable products. It ensures that all ampoules are handled in a contamination-free environment and are compliant with GMP

and regulatory requirements.

2. Scope

This procedure applies to all ampoules used in sterile manufacturing areas during filling operations at [Company Name], covering activities such as unloading, washing, sterilization, transfer, and handling until the point of filling.

3. Responsibilities

  • Production Personnel: Responsible for handling ampoules as per the SOP and maintaining proper documentation.
  • Engineering Department: Maintain and calibrate ampoule processing equipment.
  • QA Department: Monitor compliance, perform area clearance, and ensure GMP adherence.
  • QC Department: Perform sampling, inspection, and quality testing of ampoules as needed.

4. Accountability

The Head of Production shall be accountable for execution of sterile handling operations. The QA Head is accountable for ensuring compliance with cGMP and regulatory standards.

See also  Sterile Injectable Manufacturing: SOP for Operation of Lyophilizers in Injectable Production - V 2.0

5. Procedure

5.1 Receiving and Preliminary Inspection

  1. Receive ampoules from the approved supplier along with Certificate of Analysis (CoA).
  2. Visually inspect ampoules for physical damage, dirt, particulate matter, and packaging defects.
  3. Segregate rejected ampoules and document findings in the Incoming Material Inspection Log.

5.2 Storage Prior to Use

  1. Store ampoules in the quarantine area at ambient conditions away from direct sunlight.
  2. Ensure FIFO (First In First Out) principle is followed for dispensing to production.

5.3 Washing of Ampoules

  1. Transfer ampoules to the washing area using stainless steel (SS) trays.
  2. Place ampoules into the ampoule washing machine with necks facing downward.
  3. Use pre-validated washing cycles including:
    • External wash with WFI
    • Internal wash with compressed air and WFI
    • Final rinse with WFI and clean compressed air
  4. Visually inspect 10 randomly selected ampoules for cleanliness after washing.
  5. Record the washing cycle details in the Ampoule Washing Log (Annexure-1).

5.4 Depyrogenation (Sterilization)

  1. Transfer washed ampoules to a depyrogenation tunnel or hot air sterilizer.
  2. Set validated parameters (e.g., 300°C for 45 minutes for dry heat tunnel).
  3. Use temperature data logger to confirm cycle compliance.
  4. After sterilization, transfer ampoules to aseptic area using validated pass box.
  5. Record sterilization batch details in the Sterilization Logbook (Annexure-2).
See also  Sterile Injectable Manufacturing: SOP for Conducting Identity Tests on Sterile Products - V 2.0

5.5 Handling within the Aseptic Area

  1. Operators must don full sterile garments before entering the Grade A area.
  2. Handle ampoules only under LAF or RABS systems to ensure aseptic conditions.
  3. Minimize manual contact; use sterile tongs or tools wherever possible.
  4. Ensure ampoules are loaded onto the filling machine without delay post-sterilization.
  5. Do not re-sterilize ampoules once transferred into aseptic area.

5.6 Labeling and Segregation

  1. Do not label empty ampoules. Label only after final sealing and inspection.
  2. Use batch-specific identification tags during internal movement to prevent mix-ups.

5.7 Documentation and Record Keeping

  1. Maintain the following records:
    • Ampoule Washing Log
    • Sterilization Record
    • Batch Identification Tag Log
  2. QA to review and archive documents as per document control procedure.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • WFI: Water for Injection
  • QA: Quality Assurance
  • QC: Quality Control
  • SS: Stainless Steel
  • CoA: Certificate of Analysis
  • LAF: Laminar Air Flow
See also  Sterile Injectable Manufacturing: SOP for pH Testing of Injectable Products - V 2.0

7. Documents

  1. Ampoule Washing Log – Annexure-1
  2. Sterilization Record – Annexure-2
  3. Batch Identification Tag Log – Annexure-3

8. References

  • EU-GMP Guidelines Annex 1 – Manufacture of Sterile Medicinal Products
  • WHO TRS 961 Annex 6 – GMP for Sterile Pharmaceutical Products
  • ICH Q9 – Quality Risk Management

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Ampoule Washing Log

Date Batch No. No. of Ampoules Cycle No. Operator Remarks
23/06/2025 BN124A 10,000 W-2025-01 Rajesh Kumar Clean

Annexure-2: Sterilization Record

Date Batch No. Temp (°C) Time (min) Result Operator
23/06/2025 BN124A 300 45 Pass Sunita Reddy

Annexure-3: Batch Identification Tag Log

Date Batch No. Label Code Status Operator
23/06/2025 BN124A TAG-2025-A1 Applied Amit Sharma

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
10/01/2022 1.0 Initial SOP release New SOP QA Head
24/06/2025 2.0 Updated with Annexures and aseptic controls Periodic Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Gel Manufacturing: SOP for Maintaining Equipment Cleaning Logs – V 2.0
Next Post: Audit Gap: SOPs Not Aligned With Validated Cleaning Cycles

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version